Sort
64,565 grants matching “drug discovery”
MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT
$789,943University Of California Santa Cruz · U19 · FY2002 · CA
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models
$789,918Bingshan Li · Vanderbilt University · R01 · FY2023 · AG
Construct large-scale phenomes of disease and drugs and develop data-driven systems approaches to understand genetic links between Alzheimer's disease and Neuropsychiatric symptoms
$789,910Rong Xu · Case Western Reserve University · R56 · FY2018 · AG
Viral and Host Proteins as Therapeutic Targets
$789,799Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Technology to Unmask Accessible Tumor Vascular Targets
$789,795Sidney Kimmel Cancer Center · R33 · FY2004 · CA
Understanding causal mechanisms in preeclampsia through genetic instrumental variables
$789,510Ayush Giri · Vanderbilt University Medical Center · R01 · FY2022 · HL
Targeting RIPK3 in Flu-Associated Lung Injury
$789,265Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · AI
Amyloid Inhibiting Agent for Treatment of Alzheimer's
$789,141Proteotech, Inc. · R44 · FY2001 · AG
Dissecting splicing factor mutations in iPSCs
$788,895Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL
Discovery of Chemical Probes and Therapeutic Leads, Phase 3, Admin Core
$788,742Joseph M Fox · University Of Delaware · P30 · FY2025 · GM
Inhibitor Design and Synthesis
$788,603Burnham Institute For Medical Research · P01 · FY2005 · AI
MSHS Translational Science Hub
$788,593Alan J Moskowitz · Icahn School Of Medicine At Mount Sinai · KL2 · FY2019 · TR
Human Genetic determinants of HBV recovery
$788,585David L Thomas · Johns Hopkins University · R01 · FY2020 · AI
Systematic Development of Novel, Druggable Cancer Targets
$788,540Michael E. Berens · Translational Genomics Research Inst · U01 · FY2014 · CA
Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma
$788,528Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL
Development of a Next Generation Visual Performance Assessment System for Rodents
$788,405Xinmin Simon Xie · Afasci, Inc. · R44 · FY2019 · EY
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
$788,290Makedonka Mitreva · Washington University · R01 · FY2022 · AI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD
$788,244Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2025 · NS
NIDA Epidemiology Training Program
$788,219Renee M. Johnson · Johns Hopkins University · T32 · FY2017 · DA
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy
$788,203Razvan Liviu Cornea · University Of Minnesota · R01 · FY2018 · HL
Multiplexed Measurement of Psychoactive Drug Selectivity Profiles
$788,182Peter Krutzik · Primity, Inc. · R44 · FY2012 · DA
Supporting Biomedical Discovery with the ROBOKOP Graph Knowledgebase.
$787,968Alexander Tropsha · Univ Of North Carolina Chapel Hill · U24 · FY2023 · ES
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
$787,953John F Hartwig · University Of California Berkeley · R35 · FY2022 · GM
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
$787,953John F Hartwig · University Of California Berkeley · R35 · FY2021 · GM
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
$787,953John F Hartwig · University Of California Berkeley · R35 · FY2020 · GM